Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related HTWR
These Five Stocks Have Gotten A Lot Of Attention From Analysts
Benzinga's Top Downgrades
Related MSFT
What Are Wall Street's Top Analysts Saying About Microsoft Post Q4?
Tech ETFs To Buy As Microsoft Beats Big On Earnings
Emerging Markets, Tech And Momentum Plays Among Top Gainers (Investor's Business Daily)

Analysts at Goldman Sachs downgraded Heartware International (NASDAQ: HTWR) from “neutral” to “sell.” The target price for Heartware International has been lowered from $94 to $73. Heartware's shares closed at $81.26 on Friday.

Analysts at Deutsche Bank downgraded Microsoft (NASDAQ: MSFT) from “buy” to “hold.” The target price for Microsoft is set to $42. Microsoft's shares closed at $39.21 on Friday.

Morgan Stanley downgraded Mindray Medical International (NYSE: MR) from “overweight” to “equal-weight.” The target price for Mindray Medical has been lowered from $44 to $37. Mindray Medical's shares closed at $33.08 on Friday.

Analysts at Credit Suisse downgraded Enbridge (NYSE: ENB) from “outperform” to “neutral.” Enbridge's shares closed at $46.60 on Friday.

Latest Ratings for HTWR

DateFirmActionFromTo
Aug 2016BTIG ResearchTerminatesNeutral
Jul 2016Leerink SwannDowngradesOutperformMarket Perform
Jun 2016Wells FargoDowngradesOutperformMarket Perform

View More Analyst Ratings for HTWR
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (HTWR + ENB)

View Comments and Join the Discussion!